This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other congenital malformations of spinal cord
Q17_OTHER_CONGEN_MALFO_SPINAL_CORD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
51 |
4. Check minimum number of eventsNone |
51 |
5. Include endpointsNone |
51 |
6. Filter based on genotype QC (FinnGen only) |
51 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_NERVOUS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q0
- Name in latin
- Aliae malformationes congenitae medullae spinalis
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of spinal cord
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the nervous system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 561 | 319 | 242 |
| Only index persons | 443 | 266 | 177 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 14.91 | 10.34 |
| Only index persons | 22.35 | 26.14 | 16.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 51 | 32 | 19 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 45.15 | 46.58 | 42.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
29
126
4.02
5.65
2.7
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
24
92
4.04
5.58
2.4
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
34
199
3.13
3.62
4.9
3.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
30
178
2.66
2.89
2.4
2.7
nmol/l
80.0
75.8
0.38
30
161
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
24
132
2.55
2.65
1.5
1.7
pmol/l
100.3
96.0
—
9
62
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
11
6.01
2.62
15.7
6.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
20
101
2.61
2.62
3.8
4.8
%
97.0
90.3
0.73
20
101
(3014007) Fractional oxyhemoglobin in Arterial blood
6
13
5.07
2.34
7.7
8.6
%
95.5
94.7
—
6
13
(3021960) Folate [Moles/volume] in Serum or Plasma
16
78
2.53
2.20
1.3
1.3
nmol/l
25.8
23.7
0.15
16
66
(3022621) pH of Urine by Test strip
8
25
3.60
2.20
7.3
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
16
79
2.49
2.14
8.6
4.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
20
113
2.27
1.98
10.9
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
36
263
2.25
1.84
3.1
3.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
108
2.21
1.83
6.8
3.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
21
304
0.47
1.78
3.7
3.1
u/l
29.4
40.1
1.07
21
296
(3003694) ABO and Rh group [Type] in Blood
23
143
2.11
1.77
1.2
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
13
4.14
1.76
2.2
2.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
14
3.84
1.65
8.2
7.7
%
0.7
0.9
—
5
14
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
139
2.02
1.59
10.5
3.9
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
16
3.34
1.47
29.2
4.7
g/l
116.8
133.6
—
5
16
(3026008) Bacteria identified in Urine by Culture
19
117
1.99
1.45
11.2
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
48
2.35
1.38
5.0
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
18
2.96
1.31
1.8
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
19
2.80
1.24
2.4
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
20
2.66
1.18
7.2
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
20
2.66
1.18
15.6
5.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
36
287
1.86
1.17
10.8
3.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
14
83
1.95
1.16
2.7
2.0
mg/l
1.9
2.9
1.60
14
75
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
35
2.16
1.04
32.1
7.8
mmol/l
25.6
25.5
—
7
35
(3022948) Iron [Moles/volume] in Serum or Plasma
10
55
2.02
1.00
2.7
2.8
umol/l
7.4
15.9
—
10
50
(3015736) pH of Urine
22
158
1.69
0.97
4.7
3.5
—
—
—
0
0
(3012544) pH of Venous blood
8
44
1.97
0.91
23.8
6.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
135
0.52
0.89
1.3
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
66
1.85
0.87
3.0
5.5
%
24.1
23.1
—
5
35
(3007853) Bacteria identified in Skin by Aerobe culture
9
52
1.88
0.82
6.8
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
38
1.97
0.77
3.4
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
39
1.92
0.76
4.3
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
13
87
1.66
0.72
2.5
5.2
ug/l
2.0
2.0
0.00
13
75
(40768797) Stomach Pathology biopsy report
7
43
1.73
0.70
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
29
1.80
0.65
3.8
4.1
—
—
—
0
0
(3002256) Pathology report gross observation
8
52
1.64
0.63
1.4
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
30
1.74
0.63
2.4
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
19
0.00
0.61
0.0
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
22
0.00
0.61
0.0
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
23
0.00
0.60
0.0
1.3
—
—
—
0
0
(3013512) EKG study
7
108
0.59
0.56
1.3
3.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
29
332
0.71
0.51
5.1
4.1
mm/h
11.6
10.4
0.18
29
310
(3000494) Fungus identified in Specimen by Culture
7
50
1.46
0.47
3.1
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
50
1.46
0.47
3.1
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
23
190
1.38
0.47
3.3
2.7
ug/l
70.0
85.4
0.45
23
180
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
55
1.54
0.46
3.9
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7
101
0.64
0.45
5.1
3.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
31
1.68
0.44
38.4
6.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
110
0.68
0.43
2.6
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(4034850)
0
16
0.00
0.42
0.0
6.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
43
1.45
0.36
12.0
7.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
44
416
1.42
0.25
31.6
13.2
%
37.5
40.0
0.68
32
336
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
37
1.39
0.24
1.2
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
89
1.30
0.23
3.8
4.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
40
1.28
0.23
1.6
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
5
42
1.21
0.22
1.4
5.1
u/l
234.4
236.8
—
5
42
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.0
—
38.3
—
0
11
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
11
(3023420) DNA double strand Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
11
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
10
0.00
0.21
0.0
4.5
—
8.6
—
0
10
(3013290) Carbon dioxide [Partial pressure] in Blood
0
10
0.00
0.21
0.0
4.5
—
5.2
—
0
10
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.2
—
1.2
—
0
12
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.2
—
0.0
—
0
12
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
9.8
—
0
12
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
35
372
0.81
0.21
10.6
11.0
ml/min/173m2
89.8
87.0
0.25
30
301
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
17
148
1.22
0.20
6.6
3.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
108
0.80
0.14
3.0
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
43
1.18
0.10
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
31
325
0.88
0.10
3.6
3.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
46
466
0.87
0.10
10.8
9.9
u/l
28.3
26.4
0.22
46
454
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
44
1.15
0.10
5.0
5.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
63
0.77
0.09
1.8
2.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
7
63
1.13
0.08
1.1
1.4
—
590.0
—
0
16
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
83
0.82
0.08
1.7
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
12
127
0.93
0.02
5.3
9.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
14
147
0.93
0.02
3.0
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
11
106
1.05
0.00
2.0
2.4
u/l
171.1
123.9
0.29
11
101
(42870588) Differential panel, method unspecified - Blood
16
156
1.04
0.00
7.1
6.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
33.8
—
0
8
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
7
0.00
0.00
0.0
9.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
86
0.92
0.00
1.9
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
14.7
—
0
6
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
7
0.00
0.00
0.0
3.1
—
90.7
—
0
7
(3028271) Lactate [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
3.6
—
1.5
—
0
7
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
68
0.87
0.00
2.2
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
1.2
—
31.4
—
0
5
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
62
0.96
0.00
1.7
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
93.9
—
0
5
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_SPINAL_CORD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_SPINAL_CORD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_SPINAL_CORD – Other congenital malformations of spinal cord
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data